Canadian Innocan Pharma signs exclusive distribution deal with HIG

Canada-based Innocan Pharma Corporation announced that it has signed an exclusive distribution agreement with Israel-based Health Investment Group S.A. for HIG to distribute Innocan’s SHIR and Relief & Go brands in Poland. Poland’s domestic cosmetic market is rapidly growing within the European economy.

In 2020, Poland’s luxury cosmetics and perfumes market was 185 million EURO. By 2025, the value of this sector is projected to exceed EURO 221 million, according to Statista. Furthermore, Euromonitor, an esteemed market research group, recently reported that the Polish market for hemp and CBD-derived products is expected to reach a total value of 1 billion EURO by 2025.

Marius Gorsky, General Director of the IPS Holding Group commented: “Health Investment Group S.A. is excited to add Shir & Relief & Go brands to its existing distribution channels among pharmacies, pharmaceutical wholesalers and selected retail chains in Poland. “

Iris Bincovich, CEO of InnoCan Pharma: “We are humbled to add another leading European market partner such as Health Investment Group as our market-partner in Poland.


Our privacy policy